How is ER Low Used in Clinical Trials? - Metastatic Breast Cancer Trial Talk

From the Experts

Your estrogen receptor (ER) status can be found on your pathology report and is shown as a percentage. Breast cancer tumors with 1-10% of cells that are ER positive are called “ER low”. Whether ER low tumors respond well to hormone therapy and how long treatment should be given are currently unclear and being studied in clinical trials.

Visit the links below to learn more about ER low breast cancer.

ER Low Breast Cancer
MBC Clinical Trials

Last Modified on July 3, 2023



for past articles or specific information.